Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Zhongguo Zhong Yao Za Zhi ; 43(2): 390-395, 2018 Jan.
Article in Chinese | MEDLINE | ID: mdl-29552860

ABSTRACT

This study aimed to investigate the molecular mechanism and protective effect of total saponins of Panax japonicas (TSPJ) on HepG2 cells apoptosis induced by palmitic acid (PA).The HepG2 cells were cultured in vitro, and divided into five groups: the control group, the model group, the high-dose group (50 mg·L⁻¹), the middle-dose group (25 mg·L⁻¹) and the low-dose group (12.5 mg·L⁻¹).The cells of the five groups were cultured continuously for 24 hours. The cell viability was measured with MTT. HepG2 cells apoptosis was detected by Hoechest staining and Annexin V-FITC/PI staining. The protein expressions of BCL-2, CHOP and TLR4 were measured with western blotting and flow cytometry analysis. The mRNA expressions of TNF-α, IL-1ß, BCL-2, CHOP and GAPDH were measured with RT-PCR. The results suggested that compared with the control group, the number of HepG2 cells of the model group were reduced significantly (P<0.01), while the number of apoptotic HepG2 cells were increased. Compared with the model group, the number of HepG2 cells of the high-dose group and the middle-dose group were increased significantly (P<0.01), whereas the number of apoptotic HepG2 cells were reduced. Compared with the control group, TNF-α, IL-1ß and CHOP mRNA expressions and CHOP and TLR4 protein expressions in the model group were significantly up-regulated (P<0.01), while BCL-2 protein and mRNA expressions in the model group were significantly decreased (P<0.01). Compared with the model group, TNF-α, IL-1ß and CHOP mRNA expressions and CHOP and TLR4 protein expressions in the high-dose group were significantly decreased (P<0.01), while BCL-2 protein and mRNA expressions in the high-dose group were significantly up-regulated (P<0.01).In conclusion, TSPJ can reduce inflammation and apoptosis induced by palmitic acid, with a certain protective effect on liver cells.


Subject(s)
Apoptosis , Panax/chemistry , Saponins/pharmacology , Hep G2 Cells , Humans , Palmitic Acids , Phytochemicals/pharmacology
2.
Zhong Yao Cai ; 37(8): 1421-4, 2014 Aug.
Article in Chinese | MEDLINE | ID: mdl-25726652

ABSTRACT

OBJECTIVE: To investigate the protective effect of Panax notoginseng Total Saponins (PNTS) on D-galactose-induced H9c2 cell senescence and the underlying mechanism. METHODS: D-galactose was used to cause H9c2 cells senescence. Different concentrations of PNTS (5,25 and 50 µg/mL) were added into medium to protect H9c2 cells. Cell senescence was identified by senescence associated ß-galactosidase. Level of reactive oxgen species (ROS) was observed according to the effect of DCFH-DA detection. The activity of superoxide dicmutase (SOD) and the content of malondialdehyde (MDA) in cells were measured by biochemical assay kits. The apoptosis of cells was tested by Hochest. RESULTS: Compared with the control group, the number of ß-galactosidase positive cells and the fluorescence intensity of ROS in the model group were markedly increased. Meanwhile, the activity of SOD was decreased whereas the content of MDA was increased. The apoptosis level assessed by the Hochest dyeing was significantly increased with chromatin concentration and condensation. Compared with the model group, the quantity of ß-galactosidase in different PNTS treatment group was obviously decreased, the activity of SOD was increased and the content of MDA was reduced. The apoptosis rate in the cells treated with PNTS was improved. CONCLUSION: PNTS improved D-galactose-induced H9c2 cell senescence through upregulation of antioxidative ability and attenuation of cell apoptosis.


Subject(s)
Cellular Senescence/drug effects , Galactose/pharmacology , Panax notoginseng/chemistry , Protective Agents/pharmacology , Saponins/pharmacology , Apoptosis , Cell Line , Fluoresceins , Malondialdehyde
3.
Zhong Yao Cai ; 34(6): 859-64, 2011 Jun.
Article in Chinese | MEDLINE | ID: mdl-22017000

ABSTRACT

UNLABELLED: To study the anti-tumor activity of centipede extract on cervical tumor of mice and its mechanism. METHODS: The tumor-bearing mice were treated with centipede extract from two solvents [ether (CE) and alcohol (CA)] at different comcentration. The mice' life span, tumor inhibition rate and immune function were estimated. RESULTS: No mice died in CE and CA treatment groups and the tumor inhibition rate was 52.85% and 33.65% respectively. Observed the tumor tissue slices with light microscope and found infiltration of tumor cells in striated muscle in the control group but centipede treatment groups had massive necrosis and apoptosis. Karyopyknosis and apoptotic tumor cells were observed in the treatment groups under transmission electron microscopy. Compared with control group, the expression of Bax increased, the expressions of Bcl-2 and Survivin decreased, but the content of VEGF, the indexes of thymus and spleen had no significant change in treatment groups. The number of CD3+ T lymphocytes had no significant change while the ratio of CD4+ and CD8+, the number of CD19+ B lymphocytes decreaed in the CE group. The numbers of CD3+ and CD4+ lymphocytes decreased in the CA group. The pathological examine indicated no obvious change in the tissue slices of mice's liver and kidney, manifested the concentrations of CE and CA between the article's had no visible side effect. CONNCLUSION: The two extracts (CE and CA) can suppress the growth of cervical tumor and its mechanism may be related to Bax and Caspase-3 medicated the mitochondrial signal transit pathway.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Arthropods , Materia Medica/pharmacology , Uterine Cervical Neoplasms/pathology , Animals , Antineoplastic Agents/isolation & purification , Arthropods/chemistry , Cell Line, Tumor , Cell Proliferation/drug effects , Disease Models, Animal , Ethanol , Ether , Female , Gene Expression Regulation, Neoplastic/drug effects , Kidney/drug effects , Liver/drug effects , Materia Medica/isolation & purification , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Proto-Oncogene Proteins c-bcl-2/metabolism , Tumor Burden/drug effects , Uterine Cervical Neoplasms/metabolism , bcl-2-Associated X Protein/metabolism
4.
Mol Biol Rep ; 38(5): 3037-44, 2011 Jun.
Article in English | MEDLINE | ID: mdl-20127518

ABSTRACT

To determine whether the cardioprotection effect of fluvastatin mediates by toll-like receptor 4 (TLR4) signaling pathway, fifty Sprague-Dawley rats were randomly divided into five groups: sham operation group, ischemia/reperfusion (I/R) group, fluvastatin groups (high-dosage, medium-dosage, low-dosage, n = 10 in each group). Except sham operation group, the rest four groups of rats were artificially afflicted with coronary occlusion for 30 min, then reperfusion 2 h. Light microscope and transmission electronic microscope were used to observe structural changes of myocardium. RT-PCR was used to measure TLR4 mRNA expression level, TLR4 protein expression was detected by immunohistochemistry. Western blot was used to measure myocardial NF-κB protein level; ELISA was used to measure the level of TNF-α in myocardium. The results demonstrated that fluvastatin treatment markedly decreased ischemic injury caused by ischemia/reperfusion, and inhibited the expression levels of TLR4, TNF-α and NF-κB, all of which up-regulated by ischemia/reperfusion. Taken together, our results suggest that proper dosage of fluvastatin may have protective effect on the ischemic injury mediated by ischemia/reperfusion in the hearts, which might be associated with inhibition of TLR4 signaling pathway and inflammatory response during ischemia/reperfusion.


Subject(s)
Cardiotonic Agents/therapeutic use , Fatty Acids, Monounsaturated/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Indoles/therapeutic use , Myocardial Reperfusion Injury/prevention & control , Myocardium/metabolism , Toll-Like Receptor 4/metabolism , Animals , Cardiotonic Agents/pharmacology , Fatty Acids, Monounsaturated/pharmacology , Fluvastatin , Heart/drug effects , Heart/physiology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Indoles/pharmacology , Male , Myocardium/cytology , Myocardium/pathology , NF-kappa B/metabolism , Random Allocation , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects , Toll-Like Receptor 4/genetics , Tumor Necrosis Factor-alpha/metabolism
5.
J Korean Med Sci ; 25(11): 1609-15, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21060750

ABSTRACT

Activated protein C (APC) is known to be beneficial on ischemia reperfusion injury in myocardium. However, the protection mechanism of APC is not fully understood. The purpose of this study was to investigate the effects and possible mechanisms of APC on myocardial ischemic damage. Artificially ventilated anaesthetized Sprague-Dawley rats were subjected to a 30 min of left anterior descending coronary artery occlusion followed by 2 hr of reperfusion. Rats were randomly divided into four groups; Sham, I/R, APC preconditioning and postconditioning group. Myocardial infarct size, apoptosis index, the phosphorylation of ERK1/2, Bcl-2, Bax and cytochrome c genes and proteins were assessed. In APC-administrated rat hearts, regardless of the timing of administration, infarct size was consistently reduced compared to ischemia/reperfusion (I/R) rats. APC improved the expression of ERK1/2 and anti-apoptotic protein Bcl-2 which were significantly reduced in the I/R rats. APC reduced the expression of pro-apoptotic genes, Bax and cytochrome c. These findings suggest that APC produces cardioprotective effect by preserving the expression of proteins and genes involved in anti-apoptotic pathways, regardless of the timing of administration.


Subject(s)
Myocardial Reperfusion Injury/prevention & control , Myocardium/metabolism , Protein C/therapeutic use , Animals , Apoptosis , Cytochromes c/genetics , Cytochromes c/metabolism , Hemodynamics/physiology , Male , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Myocardial Reperfusion Injury/metabolism , Myocardial Reperfusion Injury/pathology , Myocardium/pathology , Phosphorylation , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Sprague-Dawley , Signal Transduction , bcl-2-Associated X Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...